DifGen Pharmaceuticals LLC (“DifGen”) announced that it has acquired Aveva Drug Delivery Services Inc. (“Aveva”) a fully integrated developer and manufacturer of Transdermal Delivery Systems (TDS) and Oral Dissolvable Films (ODF). Ramandeep Singh Jaj, Founder and Co-CEO of DifGen commented “The acquisition of Aveva Drug Delivery Services Inc with its 300 plus employees marks an important milestone for DifGen as it adds its first pharmaceutical manufacturing base in the US. This strategic investment allows us to expand our R&D & manufacturing capabilities in offering complex dosage forms and secure supply to our valuable partners with local US based manufacturing.”
Read the full article: DifGen Pharmaceuticals Acquires Aveva Drug Delivery Services Inc //
Source: https://www.prnewswire.com/news-releases/difgen-pharmaceuticals-acquires-aveva-drug-delivery-services-inc-strengthens-its-position-in-offering-difficult-and-differentiated-pharmaceuticals-dosage-forms-with-a-us-based-development-and-manufacturing-capability-301805504.html